Kristan Piroeva

New analysis by Airfinity shows there has been a 300% rise in approved new #cancer treatments in the last two decades, with the US Cancer Moonshot Goal achievable by 2048. Click below to access the full findings on global cancer #disease burden. airfinity.com/articles/300-r…

Our paper on nucleosome repositioning in CLL is now published in @genomeresearch! Led by @krissyvalp in our lab, collab with @KostareliLab, @KarstenRippe genome.cshlp.org/content/33/10/… ▶️Aggressive cancers have shorter nucleosome spacing ▶️Distinguish cancer subtypes from nuc patterns

My first first author paper is out!!!💥 Couldn’t be more excited to share all the work that started as a small project for the @GenSocUK’s Summer Studentship and turned into something a lot bigger! Would never be thankful enough to @TeifLab for giving me this opportunity!!! 🙌🏼

Airfinity is launching a brand new surveillance and analytics solution. Airfinity Biorisk covers 160 diseases and designed to equip decision makers with a holistic overview of the global infectious disease risk situation. Learn more here: airfinity.com/products/airfi…

Peer review after you win the Nobel

Where will the next #variant of concern come from? Airfinity has analysed countries where #vaccination rates are low and number of immunocompromised people is high - making mutations more likely. Read more on the analysis: @TheEconomist economist.com/graphic-detail…

What’s the mechanism? twitter.com/fred035schultz…

NucPosDB: a database of nucleosome positioning in vivo and nucleosomics of cell-free DNA biorxiv.org/content/10.110… For all nucleosome aficionados, with best wishes from Mariya Shtumpf, Kristan Piroeva, Shivam Agrawal, Divya Jacob, Vladimir Teif

@TeifLab @Airfinity Thank you, Vlad! 😊

Congratulations to our lab alumna @krissyvalp for starting a new job as a researcher at @Airfinity. We wish you all the best, Krissy!!!

Excited to share I’ll be talking about what we’ve been up to at the @TeifLab at the @INC_COST webinar this Thursday - a pretty good reason to finally join Twitter. 🔆